Nikon Corporation has invested in biotechnology startup Setsuro Tech Inc. to enhance its existing technologies and create synergies in cell production biotechnology.

Information on the Target

Setsuro Tech Inc. is an innovative biotechnology startup founded on research from Tokushima University. Located in Tokushima, Japan, the company focuses on advancing research support services and precision breeding through its proprietary genome editing technologies. Led by CEO Shinichiro Takezawa, Setsuro Tech is dedicated to developing organisms with newly engineered traits, contributing to the evolution of biotechnological applications.

The company operates out of the Fujii Memorial Institute of Medical Sciences, leveraging its cutting-edge research capabilities to offer unique solutions in the biotechnology sector. With a strong emphasis on scientific advancements, Setsuro Tech aims to position itself as a leader in genomic innovation.

Industry Overview in Japan

The biotechnology industry in Japan has seen substantial growth, driven by advancements in genetic engineering and cell production technologies. The Japanese government has actively promoted biotechnology through s

View Source

Similar Deals

HCRx CSL Vifor and Maruishi Pharmaceutical Co., Ltd.

2023

Corporate VC Proprietary & Advanced Pharmaceuticals Japan
Ricoh Lease Co., Ltd. Feed Inc.

2023

Corporate VC Medical Equipment, Supplies & Distribution (NEC) Japan
Santen Pharmaceutical Co., Ltd. Novagali Pharma S.A.

2023

Corporate VC Proprietary & Advanced Pharmaceuticals Japan
JGC Holdings Corporation Alpha Fusion

2023

Corporate VC Proprietary & Advanced Pharmaceuticals Japan
Nikki Holdings LIFESCAPES

2022

Corporate VC Advanced Medical Equipment & Technology (NEC) Japan
JGC Holdings Corporation TwoCells and MedRhythms Inc.

2021

Corporate VC Bio Therapeutic Drugs Japan

Nikon Corporation

invested in

Setsuro Tech Inc.

in 2023

in a Corporate VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert